BofA analyst Farrell Granath raised the firm’s price target on American Healthcare REIT (AHR) to $51 from $49 and keeps a Buy rating on the shares. A “silver tsunami’ in the U.S. is expected to to drive big gains for the major players in the senior housing business as Boomers age into senior living, says the analyst, who forecasts that margins for the five SHOP REITs- Welltower (WELL), Ventas (VTR), Sabra (SBRA), American Healthcare REIT and National Health Investor (NHI) – will expand ahead of Street estimates in 2026.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $50 from $45 at Citizens JMP
- American Healthcare REIT price target raised to $43 from $40 at KeyBanc
- American Healthcare REIT initiated with a Buy at UBS
- Buy Rating for American Healthcare REIT, Inc. Driven by Strong AFFO Growth and Strategic Expansion in Senior Housing
- American Healthcare REIT Announces Quarterly Distribution